AKBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akebia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.91825 USD 1.69%

Market Cap: $246.3m

	Akebia Therapeutics Inc NASDAQ:AKBA	US
D	Delta Air Lines Inc BMV:DAL	US
	Black Diamond Therapeutics Inc NASDAQ:BDTX	US
	Systemair AB STO:SYSR	SE
F	Fifth Third Bancorp XMUN:FFH	US
F	Fortress Real Estate Investments Ltd JSE:FFB	ZA
K	Keystone Realtors Ltd NSE:RUSTOMJEE	IN
V	Verizon Communications Inc DUS:BAC	US
N	New York Times Co DUS:NYT	US

Profitability Summary

Akebia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

83%

Gross Margin is Increasing

80% > 82%

Negative Operating Margin

-3%

Negative 3Y Average Operating Margin

-10%

Operating Margin is Increasing

-46% > -3%

Negative Net Margin

-14%

Negative 3Y Average Net Margin

-21%

Net Margin is Increasing

-51% > -14%

Exceptional Free Cash Flow Margin

13%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-17% > 13%

Negative ROE

-109%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-8%

ROIC is Increasing

-34% > -3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.